Magellan Health (MGLN) Tops Q4 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Six dead in 'stampede-like' incident at India temple, ANI says
Magellan Health Services (MGLN) PT Lowered to $88 at Jefferies
February 27, 2017 7:56 AM ESTJefferies lowered its price target on Magellan Health Services (NASDAQ: MGLN) to $88.00 (from $89.00) while maintaining a Buy rating. Management reiterated its 2017 revenue and EBITDA outlook.
Analyst David Styblo commented, "We believe mixed 4Q results and a small EPS guidance reduction (share... More
